QPPV.COM KNOWLEDGE ASSESSMENT

What is EudraVigilance? Knowledge Assessment

Test your understanding of the concepts covered by What is EudraVigilance?.

Question 1 of 10Pass mark: 80%

Question 1 of 10 What is the appropriate interpretation of the EMA Medical Literature Monitoring programme for an MAH?

The MAH may rely on centrally generated cases within the programme's scope but must still address literature outside that coverage The programme removes every literature-monitoring responsibility from all MAHs The programme covers all scientific literature for every active substance The programme produces aggregate reports but does not create or provide ICSRs

Question 2 of 10 Which evidence would most directly help demonstrate that an organisation's acknowledgement-review process operates effectively during an inspection?

System records showing acknowledgement review, investigation of rejected messages and documented corrective follow-up A procedure stating that acknowledgements should be reviewed, with no completed examples A list of all products marketed by the organisation A statement that the reporting gateway has never experienced a technical issue

Question 3 of 10 Why is reconciliation between downloaded EudraVigilance cases and internal safety systems important?

It can identify missing cases, duplicates, processing delays and transmission failures It proves that every reported reaction was caused by the medicinal product It removes the need to investigate rejected submissions It ensures that only serious cases remain in the safety database

Question 4 of 10 Why might a large pharmaceutical company use gateway reporting rather than manual EVWEB submissions?

Gateway connections support high-volume, automated and scalable E2B(R3) message exchange Gateway reporting eliminates the need to validate cases Gateway reporting is intended only for literature monitoring Gateway reporting prevents the company from receiving acknowledgements

Question 5 of 10 A signal team identifies an unusual reporting pattern in EVDAS. What is the most appropriate professional interpretation?

The pattern is a potential safety concern requiring appropriate validation and evaluation, not automatic proof of causality The pattern conclusively proves that the product caused every related event The pattern can be ignored because EVDAS contains only administrative information The pattern automatically requires immediate product withdrawal

Question 6 of 10 Which example most directly represents a data-quality issue that may cause an electronic ICSR to fail validation?

A missing mandatory field or invalid E2B(R3) message structure A completed acknowledgement review with no warnings A documented periodic access review A trend analysis performed using EVDAS

Question 7 of 10 Why should a QPPV understand how downloaded EudraVigilance cases are incorporated into the organisation's safety processes?

External cases may affect case processing, signal detection, aggregate reporting, benefit-risk assessment and reconciliation Downloaded cases have no impact after they are viewed by a safety physician Downloaded cases are relevant only to the information-technology department The QPPV needs this knowledge only when preparing a marketing authorisation application

Question 8 of 10 Which activity is most characteristic of Level 2B access?

Broader signal management and analytical review, including trend or disproportionality analysis Manual creation of a single ICSR through a web form Maintaining individual user training records only Correcting a product's marketing authorisation details in XEVMPD

Question 9 of 10 Which combination best captures the main inspection perspective described for EudraVigilance activities?

Inspectors assess both documented procedures and evidence that reporting, reconciliation, signal management and access controls operate effectively Inspectors focus exclusively on whether a written procedure exists Inspectors assess only the technical design of the gateway and not pharmacovigilance governance Inspectors review only serious cases and disregard non-serious reports and follow-up activities

Question 10 of 10 What does E2B(R3) primarily provide in electronic safety reporting?

A standardised structure and message format for transmitting ICSRs A clinical method for determining whether an adverse reaction is serious A system for granting medicinal product marketing authorisations A database containing only literature-derived adverse reactions

What is EudraVigilance? Knowledge Assessment

Cookie Settings